However, one study reported that continuous subcutaneous insulin infusion in T1D patients improved levels of CD34+KDR+ cells more effectively than multiple daily injections, linking the improvement to lower glucose variability [25]. The gene discussed is CD34; the disease is type 1 diabetes mellitus.